Xeris Pharmaceuticals, Inc. Skyrocketed
Fri, May 22, 2020 at 05:30 PM
Xeris Pharmaceuticals, Inc. (XERS:NASDAQ) rocketted at $5.8, a gain of 28%. On Thu 21 May 20, XERS:NASDAQ touched a New 2-Week High of $4.53. The stock got featured on our News Catalysts scanner on Fri 22 May 20 at 08:47 AM in the 'BIOTECH' category. From Thu 07 May 20, the stock recorded 80.00% Up Days and 72.73% Green Days
About Xeris Pharmaceuticals, Inc. (XERS:NASDAQ)
Xeris Pharmaceuticals Inc is a specialty pharmaceutical company leveraging its novel non-aqueous formulation technology platforms, XeriSol and XeriJect, to develop and commercialize ready-to-use injectable and infusible drug formulations.
Top 10 Gainers:
- Yunhong International (ZGYH:NASDAQ), 100%
- Navidea Biopharmaceuticals, Inc. (NAVB:NYSEMKT), 91.34%
- XpresSpa Group, Inc. (XSPA:NASDAQ), 70.21%
- Sundial Growers Inc. (SNDL:NASDAQ), 39.69%
- Renren Inc. (RENN:NYSE), 38.03%
- Genesis Healthcare, Inc. (GEN:NYSE), 35.06%
- Mitcham Industries, Inc. (MIND:NASDAQ), 32.03%
- Celsion Corporation (CLSN:NASDAQ), 28.94%
- Xeris Pharmaceuticals, Inc. (XERS:NASDAQ), 28.04%
- Seelos Therapeutics, Inc. (SEEL:NASDAQ), 27.45%